sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > Angiogenesis > EGFR > AG 494
AG 494  
Catalog No. T4205    CAS 133550-35-3
Pack Size
Availability
Price/USD
Quantity
2mg
In stock
50.00
5mg
In stock
86.00
10mg
In stock
154.00
25mg
In stock
333.00
50mg
In stock
647.00
1 mL * 10 mM (in DMSO)
In stock
86.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.50% COA Datasheet HNMR LCMS
Biological Activity:

Product Description:

AG-494 is an inhibitor of epidermal growth factor receptor kinase.

Target:
EGFR kinase; EGFR kinase;
Research Area:
Chemical Information:
Molecular Weight 280.283
Formula C16H12N2O3
CAS Number 133550-35-3
Solubility DMSO:14 mg/mL (50 mM);Ethanol:1.4 mg/mL (5 mM)
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
  • The compound is not included in our libraries at this moment.
Product Recommendations
  • Dabigatran Etexilate Mesylate, Dabigatran etexilate mesylate is the orally active prodrug of dabigatran. Dabigatran is a reversible...
  • WDR5-0103 hydrochloride[890190-22-4(free base)], WDR5-0103 is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd: 450 nM)...
  • AKOS B018304, AKOS B018304 is an arylalkylidene derivative, with polar substitution at para-position.
  • dBET6, dBET6 is a selective and cell-permeable degrader of BET based on PROTAC (IC50: 14 nM). It has antitu...
  • Fupentixol Dihydrochloride, Flupentixol is used in therapy of schizophrenia as well as in anxiolytic and depressive disorders.

 

Reference

If you have additional questions, Please send us a message. * Required